Details Basic Details Status Ongoing Last Updated Tuesday, October 1, 2024 Original Posting Date Tuesday, October 1, 2024 Health Outcome(s) signal identification Purpose Signal Identification Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Analytic Code Link(s) (2) Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis Result(s) (2) Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis